Log In
BCIQ
Print this Print this
 

pGM169/GL67A

  Manage Alerts
Collapse Summary General Information
Company Imperial Innovations Group plc
DescriptionNebulized plasmid DNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) gene complexed with a cationic liposome
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Orphan Drug (Treat cystic fibrosis (CF));
EU - Orphan Drug (Treat cystic fibrosis (CF))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today